FDA Drug recall D-0396-2021
NP Thyroid 30 Thyroid Tablets, USP 1/2 grain (30 mg), packaged in a) 100-count bottles (NDC 42192-329-01) and b) 7-count bottles (NDC 42192…
- FDA Drug
- Class I
- terminated
- Published 2021-06-02
On 2021-06-02 the FDA classified a Class I recall of NP Thyroid 30 Thyroid Tablets, USP 1/2 grain (30 mg), packaged in a) 100-count bottles (NDC 42192-329-01) and b) 7-count bottles (NDC 42192… by Acella Pharmaceuticals, citing subpotent Drug.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0396-2021 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2021-04-29 |
| Published | 2021-06-02 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Acella Pharmaceuticals |
| Distribution | US |
Product
NP Thyroid 30 Thyroid Tablets, USP 1/2 grain (30 mg), packaged in a) 100-count bottles (NDC 42192-329-01) and b) 7-count bottles (NDC 42192-329-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005
Reason
Subpotent Drug
Identifiers
| ndc | 42192-327-01 |
|---|---|
| ndc | 42192-327-30 |
| ndc | 42192-327-90 |
| ndc | 42192-329-01 |
| ndc | 42192-329-30 |
| ndc | 42192-329-10 |
| ndc | 42192-329-90 |
| ndc | 42192-330-01 |
| ndc | 42192-330-30 |
| ndc | 42192-330-10 |
| ndc | 42192-330-90 |
| ndc | 42192-331-01 |
| ndc | 42192-331-30 |
| ndc | 42192-331-10 |
| ndc | 42192-331-90 |
| ndc | 42192-328-01 |
| ndc | 42192-328-30 |
| ndc | 42192-328-90 |
| ndc | 42192-329-07 |
| code_info | Lots: a) M329D20-1, M329D20-2, M329D20-3 Exp. 03/31/2022, ; b) M329D20-2 Exp. 03/31/2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0396-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.